Michael McTague, Ph.D., is executive vice president at private equity firm Able Global Partners in New York.
Latest Articles
Governance
Elon Musk, like Caesar, has a knack for triggering the knife-wielders
Environment
Swine flu is replacing COVID on pharmaceutical companies’ target list
Investors
Buying and holding stocks may not be the fashionable strategy, but it is working
Health
Obesity, oncology and old age: How 2023 pharmaceutical M&A is reshaping the health-care industry
Health
The secret to Japan’s long life expectancy isn’t all about health
Health
Amazon’s Steady Advance Into Healthcare
Health
In Pharma, Taking a Closer Look at Next Level Down Opportunities
Health
A Look at Pharma M&A — Consolidating Strengths In Oncology, Immunology and More
Health
Pharma M&A Shows an Industry Looking to Specialize
Health
The Long List of Pharmaceuticals in Short Supply
Financial Myths: A Stitch in Time, Part II
Myth No. 2: Some Common Sense About Executive Bonuses
Financial Myths: Where There’s Smoke, There’s Fire — Part III
Health
Obesity, oncology and old age: How 2023 pharmaceutical M&A is reshaping the health-care industry
Thought Leaders
The Year in Review: Michael McTague
